NYU Langone Health
New York, 10016, United States
NCT Number: NCT06215703
This study will enroll stroke patients and healthy participants. Participants will complete baseline measures followed by a music playing task during fMRI and simultaneous measurement of motor response using electromyography (EMG) and accelerometry and affective response using electrodermal activity (EDA) and self-reports. The music task consists of tapping an MRI-compatible MIDI drum with either: (1) improvisation or maintaining the beat and (2) live or recorded piano accompaniment. The primary objectives are to identify the motor, affective, and neural outcomes of improvisation and live accompaniment in music playing tasks.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Interventional
Not applicable
New York, 10016, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For participants with stroke, to be eligible to participate in this study, an individual must meet all the following criteria:
For neurologically normal control (NC) participants, to be eligible to participate in this study, an individual must meet all the following criteria:
Exclusion criteria
For the music playing task, participants will tap on an MRI compatible MIDI drum in response to music, while following directions to either (1) maintain the beat of the music or (2) improvise a beat along with the music. Piano accompaniment for drum playing will be provided either (1) with a recording or (2) by a live music therapist. Participants will complete all four combinations of these music playing tasks following the sequence of experimental order 3. Each of the four tasks will be repeated with four one-minute songs, resulting in a total of 16 minutes of drum playing required to complete the study procedures. Participants will repeat the same task order with each song to facilitate task comprehension and task completion accuracy. Song order will be randomized for all participants.
Time frame: Day 1 (About 3 hours)
This measurement will be taken using an MRI-compatible accelerometer attached to the hand with a Velcro strap.
Time frame: Day 1 (About 3 hours)
This measurement will be taken using an MRI-compatible accelerometer attached to the hand with a Velcro strap.
Time frame: Day 1 (About 3 hours)
This measurement will be taken using an MRI-compatible accelerometer attached to the hand with a Velcro strap.
Time frame: Day 1 (About 3 hours)
This measurement will be taken using an MRI-compatible accelerometer attached to the hand with a Velcro strap.
Time frame: Day 1 (About 3 hours)
This measurement will be taken using MRI-compatible electromyography sensors placed on the arm.
Time frame: Day 1 (About 3 hours)
This measurement will be taken using MRI-compatible electromyography sensors placed on the arm.
Time frame: Day 1 (About 3 hours)
This measurement will be taken using MRI-compatible electromyography sensors placed on the arm.
Time frame: Day 1 (About 3 hours)
This measurement will be taken using MRI-compatible electromyography sensors placed on the arm.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Summary beta values representing the level of brain activity will be calculated.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Summary beta values representing the level of brain activity will be calculated.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Summary beta values representing the level of brain activity will be calculated.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Summary beta values representing the level of brain activity will be calculated.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Summary beta values representing the level of brain activity will be calculated.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Summary beta values representing the level of brain activity will be calculated.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Summary beta values representing the level of brain activity will be calculated.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Summary beta values representing the level of brain activity will be calculated.
Time frame: Day 1 (About 3 hours)
EDA is a procedure for measuring emotional excitement by recording the skin's natural electrical activity. The measurements will be taken using two MRI-compatible sensors attached to the palm of the hand.
Time frame: Day 1 (About 3 hours)
EDA is a procedure for measuring emotional excitement by recording the skin's natural electrical activity. The measurements will be taken using two MRI-compatible sensors attached to the palm of the hand.
Time frame: Day 1 (About 3 hours)
EDA is a procedure for measuring emotional excitement by recording the skin's natural electrical activity. The measurements will be taken using two MRI-compatible sensors attached to the palm of the hand.
Time frame: Day 1 (About 3 hours)
EDA is a procedure for measuring emotional excitement by recording the skin's natural electrical activity. The measurements will be taken using two MRI-compatible sensors attached to the palm of the hand.
Time frame: Day 1 (About 3 hours)
The questionnaire includes 1 question measuring participant's pleasure while performing the music activity. The item is rated on a Likert scale from 1 (low) to 5 (high); higher scores indicate greater pleasure.
Time frame: Day 1 (About 3 hours)
The questionnaire includes 1 question measuring participant's pleasure while performing the music activity. The item is rated on a Likert scale from 1 (low) to 5 (high); higher scores indicate greater pleasure.
Time frame: Day 1 (About 3 hours)
The questionnaire includes 1 question measuring participant's pleasure while performing the music activity. The item is rated on a Likert scale from 1 (low) to 5 (high); higher scores indicate greater pleasure.
Time frame: Day 1 (About 3 hours)
The questionnaire includes 1 question measuring participant's pleasure while performing the music activity. The item is rated on a Likert scale from 1 (low) to 5 (high); higher scores indicate greater pleasure.
Time frame: Day 1 (About 3 hours)
The questionnaire includes 1 question measuring participant's cognitive challenge while performing the music activity. The item is rated on a Likert scale from 1 (low) to 5 (high); higher scores indicate greater cognitive challenge.
Time frame: Day 1 (About 3 hours)
The questionnaire includes 1 question measuring participant's cognitive challenge while performing the music activity. The item is rated on a Likert scale from 1 (low) to 5 (high); higher scores indicate greater cognitive challenge.
Time frame: Day 1 (About 3 hours)
The questionnaire includes 1 question measuring participant's cognitive challenge while performing the music activity. The item is rated on a Likert scale from 1 (low) to 5 (high); higher scores indicate greater cognitive challenge.
Time frame: Day 1 (About 3 hours)
The questionnaire includes 1 question measuring participant's cognitive challenge while performing the music activity. The item is rated on a Likert scale from 1 (low) to 5 (high); higher scores indicate greater cognitive challenge.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI).
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Psychophysiological interactions (PPI) analysis will be used with the seed in the ventral striatum.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Psychophysiological interactions (PPI) analysis will be used with the seed in the ventral striatum.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Psychophysiological interactions (PPI) analysis will be used with the seed in the ventral striatum.
Time frame: Day 1 (About 3 hours)
Measured using functional MRI (fMRI). Psychophysiological interactions (PPI) analysis will be used with the seed in the ventral striatum.
NYU Langone Health
Other
Optimizing Music-based Interventions for Stroke: a Mechanistic Crossover Study of the Effects of Music Improvisation and Live Accompaniment on Motor, Autonomic, and Neural Response During a Music Playing Task Among Survivors of Stroke and Matched Healthy Control Participants
Acronym: OptiMUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT07736573
Brain Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial Details